(AGENPARL) - Roma, 21 Giugno 2023 - (AGENPARL) – BARCELONA mer 21 giugno 2023
Nuage Therapeutics raises €12M in Seed Financing led by Sofinnova Partners and Asabys
EnzoAndres.Crisosto
Wed, 06/21/2023 – 08:33
Nuage Therapeutics (“Nuage”), a biotech company developing a drug discovery engine for small molecule modulators of intrinsically disordered proteins (IDPs), announces today the successful closing of a €12 million Seed financing to support the development of its lead program and validate its pioneering drug discovery platform.